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Objective: To evaluate the associations between first trimester 25-hydroxyvitamin D 
[25(OH)D] status and changes in high-density lipoprotein cholesterol (HDL-c), low-
density lipoprotein cholesterol (LDL-c), total cholesterol (TC), triglyceride (TG) 
concentrations, TG/HDL-c, and TC/HDL-c ratios throughout pregnancy. We 
hypothesized that first trimester 25(OH)D inadequacy is associated with lower 
concentrations of HDL-c and higher LDL-c, TC, TG, TG/HDL-c, and TC/HDL-c ratios 
throughout pregnancy.  
Methods: A prospective cohort study with 3 visits at 5-13 (baseline), 20-26, and 30-36 
gestational weeks, recruited 194 pregnant women attending a public health care center 
in Rio de Janeiro, Brazil. Plasma 25(OH)D concentrations were measured in the first 
trimester using liquid chromatography-tandem mass spectrometry. 25(OH)D 
concentrations were classified as adequate (≥ 75 nmol/L) or inadequate (< 75 nmol/L). 
Serum TC, HDL-c, and TG concentrations were measured enzymatically. Crude and 
adjusted longitudinal linear mixed-effects models were employed to evaluate the 
association between the first trimester 25(OH)D status and changes in serum lipid 
concentrations throughout pregnancy. Confounders adjusted for in the multiple analysis 
were age, homeostatic model assessment (HOMA), early pregnancy BMI, leisure time 
physical activity before pregnancy, energy intake, and gestational age.  
Results: At baseline, 69% of the women had inadequate concentrations of 25(OH)D. 
Women with 25(OH)D inadequacy had higher mean LDL-c than those with adequate 
concentrations (91.3 vs 97.5 mg/dL; P = 0.064) at baseline. TC, HDL-c, LDL-c TG, 
TG/HDL-c ratios, and TC/HDL-c ratios, increased throughout pregnancy independently 












models showed direct associations between the first trimester 25(OH)D status and 
changes in TC (β = 9.53; 95%CI = 1.12-17.94), LDL-c (β = 9.99; 95% CI = 3.62-16.36) 
concentrations, and TC/HDL-c ratios (β = 0.16; 95% CI = 0.01-0.31) throughout 
pregnancy.  
Conclusions: Inadequate plasma 25(OH)D concentrations during early pregnancy were 
associated with more pronounced changes of TC, LDL-c concentrations, and TC/HDL-c 
ratios throughout pregnancy. Changes in these cardiovascular markers suggest the 
importance of ensuring adequate vitamin D status at the beginning of pregnancy. 
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1. Introduction 
During pregnancy, physiological changes in carbohydrate and lipid metabolism 
are associated with increases in TC, TG, HDL-c, and LDL-c. [1,2]. Although these 
changes in the maternal serum lipid profile are thought to be normal adaptations to 
support fetal development, studies have shown that some factors such as being 
overweight [1], sedentary behavior [3], smoking [4], vitamin B1 (thiamine) and B2 
(riboflavin) deficiency [5] and lifestyle [6] negatively influence this increase. 
 There is increasing evidence shown that an abnormal lipid profile during 
gestation may increase the risk of cardiovascular disease and result in undesirable 
outcomes for the mother and the fetus, including preeclampsia [7,8], gestational 
diabetes mellitus [9,10], intrauterine growth restriction and premature birth [11,12]. 
Recent clinical trials and observational studies have shown that adequate serum 
concentrations of 25(OH)D are related to a better lipid profile in children, adolescents, 












increase in blood pressure (BP) and markers of cardiovascular disease risk [16,17]. 
Vitamin D is thought to modify cardiometabolic processes, either directly by the actions 
of its nuclear vitamin D receptor [18] or indirectly by regulation of calcium homeostasis 
[19]. 
Vitamin D inadequacy has been described as a pandemic condition and a serious 
public health problem, with a high prevalence worldwide in adult women, including 
77% in Brazil, 73% in Australia, 84% in Scotland, and 83% in Nigeria [20]. Similar 
prevalences were found in pregnant women in other parts of the world, such as 
Germany (77%), Belgium (74%), and Pakistan (79%) [20]. The lack of prospective 
studies investigating the association between vitamin D status and lipid changes 
throughout pregnancy, combined with the high prevalence of vitamin D inadequacy 
among women of reproductive age, [20,21] highlight the importance of the current 
study. 
The purpose of this study was to evaluate the associations between first trimester 
25(OH)D status and subsequent changes in HDL-c, LDL-c, TC, TG concentrations, and 
TG/HDL-c and TC/HDL-c ratios during the course of pregnancy. We hypothesize that 
first trimester 25(OH)D inadequacy is associated with lower concentrations of HDL-c, 





2.1 Study design and eligibility criteria 












prenatal care center in Rio de Janeiro, Brazil, between November 2009 and October 
2011. The eligibility criteria to participate comprised recruitment between the fifth and 
thirteenth gestational weeks, age of 20-40 years, lack of chronic diseases (except 
obesity) and infectious diseases, singleton pregnancy, and residence in the catchment 
area of the prenatal care center. 
 Interviews and blood samples were taken at 3 time points: 5-13 (baseline), 20-
26, and 30-36 weeks gestation. A total of 322 women met the eligibility criteria and 
were invited to participate. From those 322 women, 23 chose not to participate, and 105 
were excluded after enrollment for the following reasons: diagnosed with chronic 
diseases (n = 12) or with infectious diseases (n = 9), advanced pregnancy at baseline (≥ 
14 weeks of gestation) (n = 15), multiple pregnancies (n = 4), missed the baseline 
interview (n = 5) or the baseline blood collection (n = 6) or suffered early miscarriages 
(n = 25), missing information on 25(OH)D concentration (n = 4), or missing 
information on the lipid profile (n = 19) or confounders at baseline (n = 6). The baseline 
sample comprised 194 pregnant women. From the baseline to the second trimester visit, 
10 follow-up losses occurred; women who moved out of the program (n = 5) and 
women who abandoned prenatal care (n = 5) were excluded, leaving 184 women at the 
second trimester visit. Between the second and third visits, women moved out of the 
program catchment area (n = 1), abandoned prenatal care (n = 1), or had missing 
information on their lipid profile (n = 3) or confounders (n = 18) and so were excluded 
from the analyses. The final sample in the third trimester was 161 women 
(Supplemental Figure 1).  
     












Maternal blood sample collection (5 mL) was performed between 6:50 am and 
7:50 am by a trained technician (nurse) after 12 hours of fasting. Blood samples were 
collected into vacutainer tubes at 3 different clinic visits (first, second, and third 
gestational trimesters). Maternal blood samples were immediately centrifuged (5,000 
rpm for 5 minutes), and aliquots of serum (prepared from blood collected in tubes with 
gel separator) and plasma (prepared from blood collected in tubes containing EDTA) 
were stored at -80°C until analysis. 
 
2.3 Vitamin D status 
The first trimester plasma concentrations of 25(OH)D were determined by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) at Quest Diagnostics Nichols 
Institute (San Juan Capistrano, CA, USA) using the LC Thermo Cohesive System 
coupled to a Thermo Quantum Ultra Mass Spectrometer (Thermo Fisher; San Jose, CA, 
USA). This laboratory is part of the Hormone Standardization Program of the Centers 
for Disease Control and Prevention. LC-MS/MS is the best assay available and has high 
sensitivity and specificity with analytical measurement ranging from 10 to 640 nmol/L. 
[22]. Interclass and intraclass variability were < 10%. 
Women were classified as having either adequate, 25(OH)D ≥ 75 nmol/L, or 
inadequate, 25(OH)D < 75 nmol/L, vitamin D status as recommended for pregnant 
women by the Endocrine Society Practice Guidelines [22]. 
 
2.4 Lipid profile 
The lipid profile outcomes in this study were HDL-c, TC, TG, LDL-c, TC/HDL, 












and TG concentrations using an enzymatic colorimetric method in an automated 
analyzer (Labmax Plenno, Labtest Diagnostica, Minas Gerais, Brazil) and commercial 
kits (Labtest Diagnostica, Minas Gerais, Brazil). LDL-c was calculated using the 
Friedewald, Levy, and Fredrickson (1972) formula. [23].  
 
2.5 Covariates assessment 
Early maternal body weight was measured to the nearest 0.1 kg between the fifth 
and thirteenth gestational weeks using an electronic scale (Filizzola Ltd., São Paulo, 
Brazil). Height was measured in duplicate using a portable stadiometer (Seca Ltd., 
Hamburg, Germany) at baseline to the nearest 0.1 cm. Early BMI was calculated using 
the formula weight (kg)/height (m)2 The cut points proposed by the World Health 
Organization and endorsed by the Institute of Medicine (IOM) (2009) [24] were used to 
classify the women’s BMI in early pregnancy. All anthropometric measurements were 
obtained according to standardized procedures and recorded by trained interviewers. 
[25]. 
In the first trimester, a validated semi-quantitative Food Frequency 
Questionnaire (FFQ) was administered by trained interviewers; this FFQ is an updated 
version of the most commonly used FFQ in Rio de Janeiro, Brazil [26]. Total vitamin D 
(mg/day) and energy (kcal/day) intakes were estimated based on the daily frequency of 
intake and portion sizes reported for each FFQ food item. A Brazilian household 
measures table was used to quantify portion sizes that were converted into grams or 
milliliters. [27]. The nutrient database was constructed primarily with the nutritional 
composition of food consumed [28] and complemented by the database developed by 












Gestational age was measured via ultrasound performed before 24 weeks of 
gestation (n = 171, 88.1%). If this information was not available in the obstetric record, 
gestational age was calculated based on the reported date of the last menstrual period (n 
= 23, 11.9%). 
Plasma insulin concentrations were determined using an enzyme-linked 
immunosorbent assay (ELISA) (Millipore, St. Charles, MO, USA) with sensitivity of 2 
µU/mL. Insulin resistance was estimated by calculating the homeostasis model 
assessment-insulin resistance (HOMA-IR = fasting insulin [U/ml] x fasting glucose 
[mmol/L]/22.5) [30]. 
 
2.6 Statistical analysis 
We compared mean concentrations of 25(OH)D, lipid outcomes, and relevant 
confounders measured at baseline between the women who reached the final follow-
up (n = 161) and those who were lost to follow-up or excluded from the analysis (n = 
33). The chi-squared test was applied for categorical variables and Student’s t-test for 
continuous variables. 
The characteristics of pregnant women were described as means and standard 
deviation (SD) for continuous variables and as absolute (n) and relative frequency (%) 
for categorical variables according to first trimester 25(OH)D status. Means were 
compared using Student’s t-test and proportions using the chi-squared test. The trend 
of the lipid profile outcomes throughout pregnancy was compared using ANOVA for 
repeated measures.  
Crude and adjusted longitudinal linear mixed-effect (LME) regression models 












changes in lipid profiles during pregnancy. An independent model for each outcome 
(TC, LDL-c, HDL-c, TG, TC/HDL, and TG/HDL) was performed. Confounders were 
added to the model based on biological plausibility and statistical significance in 
bivariate regression models (P < 0.2) with both the main exposure, 25(OH)D status, and 
the lipid profile outcomes (HDL-c, TC, TG, LDL-c, TC/HDL-c, and TG/HDL-c). The 
following variables reached this condition and were included in the adjusted models: 
age, early pregnancy BMI, total energy intake, parity, leisure time physical activity 
before pregnancy, HOMA-IR, and gestational age. Quadratic gestational age was 
further included in adjusted models (except for TG) as the association between TC and 
fractions during pregnancy with time showed a non-linear function. The season of 
measurement of 25(OH)D, although associated with the main exposure, had no 
relationship with the lipid profile outcomes. Therefore, seasonality was not considered 
as a confounder and was not included in the adjusted models. 
The maximum likelihood ratio and Akaike information criterion were 
considered to select the most parsimonious model, and the unstructured covariance 
matrix was used in all models.  
Effect plots containing data scatter, longitudinal prediction, and 95% 
confidence intervals (CIs) were constructed to illustrate the variation in lipid 
concentrations during pregnancy according to 25(OH)D status in the first trimester. 
Statistical analyses were performed using Stata Data Analysis and Statistical 















The Rio de Janeiro Municipal Health Secretary Research Ethics Committee 
approved the study procedures (reference number: 0139.0.314.000-09). Written 
informed consent was obtained from each volunteer before entry into the study.  
 
3. Results 
No differences were found regarding 25(OH)D or lipid profile concentrations at 
baseline between women who completed the follow-up and to those classified as lost to 
follow-up or excluded (Supplemental Table 1).  
The mean age of the women was 26.7 years (SD = 5.5). Twenty five percent (n 
= 49) of the women reported leisure time physical activity before pregnancy and 38.6% 
(n = 75) were nulliparous. Sixty-nine percent (n = 135) of women had inadequate 
concentrations of 25(OH)D at baseline. The majority of women (59.8%) had normal 
weight, 26.8% were overweight, and 13.4% were obese according to early pregnancy 
BMI (kg/m²). TC, HDL-c, LDL-c, TG, and TC/HDL-c ratios increased throughout 
pregnancy independently of 25(OH)D concentrations (ANOVA for repeated measures P 
< 0.001) (Table 1).  
The trend of changes throughout pregnancy was positive and statistically 
significant for all lipid outcomes except for the TG/HDL ratio. This holds true even 
after adjustment for a wide range of confounders. The increment was independent of 
first trimester 25(OH)D status. The dots representing each observation are concentrated 
toward the regression line, meaning a good fit of the models (Figures 1-6).  
A direct and significant association was observed between baseline 25(OH)D 
status and changes in TC (β = 9.53; 95% CI = 1.12-17.94; P value = 0.026) and LDL-c 












when analyses were adjusted for confounders (Table 2).  
Inadequate 25(OH)D status at baseline was not associated with HDL-c (β = 
0.08; 95% CI = 2.33-2.49; P value = 0.946) and TG concentrations (β = -6.09; 95% CI 
= -15.97-3.78; P value = 0.227) or with TG/HDL-c ratios (β = -0.15; 95% CI = -0.37-
0.07; P value = 0.186) throughout pregnancy (Tables 3 and 4). However, 25(OH)D 
inadequacy was directly and significantly associated with TC/HDL-c ratio (β = 0.16; 
95% CI = 0.01-0.31; P value = 0.040) changes during pregnancy, in both crude and 
adjusted models (Table 4).  
 
4. Discussion 
To the best of our knowledge, this is the first longitudinal study to evaluate the 
association between 25(OH)D concentrations and lipid profile changes during 
pregnancy. Our findings show that women with inadequate 25(OH)D status in the 
first trimester of pregnancy presented significantly higher changes in concentrations 
of TC, LDL-c, and TC/HDL-c ratios throughout pregnancy compared to women with 
adequate vitamin D status at baseline after adjustment for a wide range of 
confounders. It is interesting to note that when analyses were performed on the 
absolute values for each lipid outcome in the point-by-point evaluation (that is, for 
each trimester assessment), no differences were found for any of the lipid outcomes 
according to baseline vitamin D status. This means that vitamin D status at baseline 
plays a role in the longitudinal changes of the lipid profile and not on the absolute 
values observed at each time point in pregnancy.  
 The mean 25(OH)D concentration in the first trimester was 65.5 nmol/L and 












The high prevalence of vitamin D inadequacy may be regarded as a serious public 
health problem. Song et al. (2013) also found a high prevalence of vitamin D 
inadequacy in a study of 125 healthy pregnant women from China and observed that 
96.8% of the women in the sample presented serum 25(OH)D concentrations < 50 
nmol/L and none had serum 25(OH)D levels ≥ 75 nmol/L in early pregnancy [33]. 
Our results also corroborate a recent study conducted in North India with 418 healthy 
pregnant women. They report that 93.5% of the women were vitamin D deficient 
(defined as a 25(OH)D concentration between 25-80 nmol/L) and 34.4% were 
severely vitamin D deficient: 25(OH)D < 25 nmol/L [34]. Furthermore, a high 
prevalence of vitamin D inadequacy (< 75 nmol/L) during pregnancy was also 
observed in other tropical or subtropical countries such as Australia and China 
[35,36].  
 The relationship between lipid profiles, vitamin D, and biomarkers of 
cardiovascular disease risk have clear clinical and public health implications. Studies 
have shown that an altered lipid profile characterized by high concentrations of 
atherogenic fractions such as high LDL-c and TG and low HDL-c during gestation 
might increase the risk of cardiovascular diseases and may also result in undesirable 
outcomes for the mother and the fetus. [7,11]. Vitamin D may be an important 
modifiable risk factor and thus should be considered as a potential target for 
interventions. Studies in humans have shown that vitamin D adequacy might be related 
to improvements in the lipid profile [13,14,15]. For instance, a recent study of 195 
adults without cardiovascular disease found that participants with coronary artery 
calcification were 3.3 times more likely (OR = 3.31, 95% CI: 1.12-9.77) to be vitamin D 












C-reactive protein, and TG when compared to those without calcification [15]. 
Consistent evidence suggests that vitamin D receptors are present in tissues, including 
the vascular endothelium [37], and myocardium [17] and have been shown to decrease 
proliferation of vascular cell smooth muscle and to improve vasodilation of the 
endothelium. Additionally, studies have suggested that low concentrations of vitamin D 
are related to cardiovascular disease, myocardial infarction, stroke, and congestive heart 
failure [38,39,40]. It is known that vitamin D plays an important role in the regulation of 
cholesterol biosynthesis. Vitamin D inhibits coenzyme A reductase (HMG CoA 
reductase) and thus inhibits cholesterol synthesis [41,42]. Furthermore, it has a potent 
anti-lipolytic action, increasing intracellular calcium levels, regulates the renin-
angiotensin system, and suppresses lipolysis in human adipocytes [43]. Nevertheless, 
little is known about these associations during gestation. 
Few studies have addressed the association between 25(OH)D and lipid 
concentrations during pregnancy. A cross-sectional study conducted with 515 Saudi 
Arabian women in the first trimester of pregnancy observed a direct correlation between 
vitamin D status and TC (r  = 0.172; P value < 0.01) and TG (r = 0.184; P value < 0.01). 
Our results also show a positive and significant association between 25(OH)D 
inadequacy and changes in TC concentrations during pregnancy. Additionally, first 
trimester inadequacy of 25(OH)D was positively and significantly associated with LDL-
c concentrations and changes during pregnancy, in both crude and adjusted models. 
Recent clinical trials have evaluated the effects of supplementation with vitamin 
D during pregnancy and several maternal and fetal outcomes. [45,46,47]. Asemi et al. 
(2013), in a randomized single-blind controlled clinical trial performed with pregnant 












carbonate calcium plus 200 IU vitamin D3) presented lower LDL concentrations 
compared to the placebo group (-10.8; SD = 22.4 vs 10.4; SD = 28.0; P value = 0.003) 
and a significantly higher reduction in TC concentrations (-11.0; SD = 23.5 vs 9.5; SD = 
36.5 mg/dL; P value = 0.01). However, no significant differences were found regarding 
serum HDL-c and TG concentrations. [45]. Samimi et al. (2016), in a prospective 
double-blind placebo-controlled trial with 60 pregnant women, found that women who 
received 50.000 IU of vitamin D3 every 2 weeks plus 1,000 mg/day of calcium 
supplements (as calcium carbonate) from 20 to 32 weeks of gestation had significantly 
increased serum HDL-c when compared to women who received a placebo (4.6; SD = 
8.3 vs -2.9; SD = 7.7 mg/dL; P value = 0.001) [48].  
The different physiological potency of vitamin D2 and D3 and the potential 
differences on the associations under study could not be investigated in our research. 
The vitamin D2 concentrations were too low and could not be detected. This may be 
explained by the fact that no women from our study reported vitamin D supplement 
intake. The use of supplements is not common among the Brazilian population, 
especially in low-income groups. The lack of mandatory vitamin D fortification in 
Brazil represents a missed window of opportunity and should be reconsidered from the 
policymakers’ perspective.  
The present study has some strengths and limitations. The main strength refers to 
the vitamin D and lipid measurements throughout pregnancy, allowing us to establish a 
trend for the lipid concentrations during pregnancy according to first trimester 25(OH)D 
status. The longitudinal design allowed us to determine directionality. Furthermore, the 
association between 25(OH)D and the lipid profile during pregnancy is quite novel and 












25(OH)D by LC-MS/MS, a method considered to be the gold standard. Regarding 
limitations in our study, information concerning an individual’s sun exposure was not 
collected. Second, there were losses of participants during follow-up (17%) that might 
have reduced our power to detect significant associations. However, our losses to 
follow-up happened to be random. Third, although associations between changes in 
serum lipids and vitamin D inadequacy have been identified in early pregnancy, our 
findings are limited since there are no validated cutoff points to define serum lipid 
abnormality during pregnancy. Finally, it is worth noting that the current analysis did 
not include data on perinatal and maternal outcomes beyond the lipid outcomes.  
In conclusion, the present study demonstrated that pregnant women with 
inadequate plasma 25(OH)D concentrations in the first trimester presented a 
significantly higher increase in TC, LDL-c, and TC/HDL-c ratios during pregnancy 
compared to those with adequate 25(OH)D concentrations, after adjustment for a 
wide range of confounders. Vitamin D deficiency is a serious public health problem 
observed in many populations around the world, including pregnant women, and even 
among people residing in sunny regions. The lipid concentrations are an important 
modifiable factor during gestation and are associated with several maternal and fetal 
outcomes. There is a need for research to investigate the associations between vitamin 
D status, serum lipids, and adverse pregnancy outcomes. Thus, strategies for 
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Figure 1. Changes in total cholesterol throughout pregnancy according to first trimester 
25(OH)D status, Rio de Janeiro/Brazil, 2009-2012. 
Note: Baseline 25(OH)D status was categorized in adequacy (≥75nmol/L) and inadequacy (<75nmol/L) and the 
adequacy was considered the reference category. The model was adjusted for age, energy intake, parity, early 
pregnancy BMI, leisure time physical activity before pregnancy, Homeostasis Model Assessment – Insulin 
Resistance and linear and quadratic gestational weeks.  





Figure 2. Changes in LDL-cholesterol throughout pregnancy according to first trimester 
25(OH)D status, Rio de Janeiro/Brazil, 2009-2012. 
Note: Baseline 25(OH)D status was categorized in adequacy (≥75nmol/L) and inadequacy (<75nmol/L) and the 
adequacy was considered the reference category. The model was adjusted for age, energy intake, parity, early 
pregnancy BMI, leisure time physical activity before pregnancy, Homeostasis Model Assessment – Insulin 
Resistance and linear and quadratic gestational weeks.  















Figure 3. Changes in HDL-cholesterol throughout pregnancy according to first trimester 
25(OH)D status, Rio de Janeiro/Brazil, 2009-2012. 
Note: Baseline 25(OH)D status was categorized in adequacy (≥75nmol/L) and inadequacy (<75nmol/L) and the adequacy 
was considered the reference category. The model was adjusted for age, energy intake, parity, early pregnancy BMI, 
leisure time physical activity before pregnancy, Homeostasis Model Assessment – Insulin Resistance and linear and 
quadratic gestational weeks.  




Figure 4. Changes in triglycerides throughout pregnancy according to first trimester 25(OH)D 
status, Rio de Janeiro/Brazil, 2009-2012. 
Note: Baseline 25(OH)D status was categorized in adequacy (≥75nmol/L) and inadequacy (<75nmol/L) and the adequacy 
was considered the reference category. The model was adjusted for age, energy intake, parity, early pregnancy BMI, 
leisure time physical activity before pregnancy, Homeostasis Model Assessment – Insulin Resistance and linear and 
quadratic gestational weeks.  


















Figure 5. Changes in TG/HDL-cholesterol ratio throughout pregnancy according to first 
trimester 25(OH)D status, Rio de Janeiro/Brazil, 2009-2012. 
Note: Baseline 25(OH)D status was categorized in adequacy (≥75nmol/L) and inadequacy (<75nmol/L) and the 
adequacy was considered the reference category. The model was adjusted for age, energy intake, parity, early 
pregnancy BMI, leisure time physical activity before pregnancy, Homeostasis Model Assessment – Insulin 
Resistance and linear and quadratic gestational weeks.  





Figure 6. Changes in TC/HDL-cholesterol ratio throughout pregnancy according to first 
trimester 25(OH)D status, Rio de Janeiro/Brazil, 2009-2012. 
Note: Baseline 25(OH)D status was categorized in adequacy (≥75nmol/L) and inadequacy (<75nmol/L) and the 
adequacy was considered the reference category. The model was adjusted for age, energy intake, parity, early 
pregnancy BMI, leisure time physical activity before pregnancy, Homeostasis Model Assessment – Insulin 
Resistance and linear and quadratic gestational weeks.  























n = 59 
Inadequate   
25(OH)D  
(<75 nmol/L) 
n = 135 
P c 
Continuous variables b 
Age (years)  26.7 (5.5) 26.8 (5.5) 26.3 (5.3) 0.565 
Early pregnancy Body Mass Index (kg/m²) 25.1 (4.8) 25.6 (6.7) 25.0 (4.3) 0.331 
Pre-pregnancy energy intake (kcal/day) 2,425 
(904) 
2,314 (811) 2,473 (940) 0.260 
Pre-pregnancy vitamin D intake (mg/day) 27.2 (35.0) 21.0 (16.0) 29.9 (40.5) 0.105 
Homeostasis Model Assessment – 
 Insulin Resistance d 
1.2 (1.0) 1.1 (0.8) 1.3 (1.1) 0.122 
Total Cholesterol (mg/dL) e     
1st trimester 158.8 (28.4) 157.1 (26.4) 159.5 (29.2) 0.584 
2nd trimester 211.3 (36.4) 208.9 (34.6) 211.8 (38.8) 0.649 
3rd trimester 224.4 (42.0) 224.1 (43.8) 225.0 (41.5) 0.902 
Low Density Lipoprotein  (mg/dL) e     
1st trimester 95.6 (21.2) 91.3 (20.6) 97.5 (21.3) 0.064 
2nd trimester 127.2 (28.9) 124.4 (30.4) 128.9 (29.3) 0.385 
3rd trimester 137.2 (33.7) 134.1 (37.7) 140.3 (31.7) 0.301 
High Density Lipoprotein (mg/dL) e     
1st trimester 47.4 (8.1) 48.6 (7.3) 46.9 (8.5) 0.179 
2nd trimester 57.6 (10.2) 57.8 (9.0) 57.2 (10.8) 0.736 
3rd trimester 55.0 (10.4) 56.3 (10.3) 54.4 (10.5) 0.321 
Triglycerides (mg/dL) e     
1st trimester 78.7 (33.3) 85.7 (38.5) 75.8 (30.4) 0.055 
2nd trimester 132.4 (49.2) 133.4 (48.5) 128.9 (50.0) 0.602 






















1st trimester 1.7 (0.7) 1.8 (0.7) 1.6 (0.8) 0.201 
2nd trimester 2.3 (1.1) 2.4 (1.14) 2.3 (1.1) 0.690 
3rd trimester 2.9 (1.1) 3.1 (1.2) 2.8 (1.0) 0.220 
Total Cholesterol/High Density Lipoprotein e     
1st trimester 3.4 (0.5) 3.2 (0.5) 3.4 (0.5) 0.036 
2nd trimester 3.7 (0.6) 3.7 (0.6) 3.7 (0.6) 0.393 
3rd trimester 4.1 (0.7) 4.0 (0.8) 4.2 (0.7) 0.272 
Categorical variables     P f 
Leisure physical activity before pregnancy     
No 143 (74.7) 40 (28.0) 103 (72.0)         0.157 
 Yes 49 (25.3) 19 (38.8) 30 (61.2) 
Parity (number of parturitions)     
0 
 
75 (38.6) 20 (26.7) 55 (73.3)             0.368 
 ≥ 1 119 (61.4) 39 (32.8) 80 (67.2) 
Early pregnancy BMI (kg/m²) d     
Normal weight   116 (59.8) 43 (72.9) 73 (54.1)  
Overweight  52 (26.8) 9 (15.2) 43 (38.1) 0.148 
 Obese  26 (13.4) 7 (11.9) 19 (7.8) 
25(OH)D (nmol/L)     
Yes 59 (30.4) -      - - 
No 135 (69.6) -       -  
a Sample size according to waves of follow-up: 1st trimester = 194; 2nd trimester = 162; 3rd trimester = 161. 
b Continuous variables described as means (standard deviation) and categorical variables as n (%). 
c p-values refer to Student’s t test comparing adequate and inadequate 25(OH)D status. 
d Sample reduction due to missing data for Homeostasis Model Assessment – Insulin Resistance = 193; Leisure physical activity before pregnancy = 192. 
e p-values for ANOVA for repeated measures throughout pregnancy <0.001. 












Table 2. Linear mixed effects regression models between first trimester 25(OH)D status and changes in lipids concentrations during pregnancy, Rio de Janeiro/Brazil, 
2009-2012. 
 










Fixed effects β (95% CI)  P
 c
 β (95% CI) P
 c
 β (95% CI) P c β (95% CI) P c 
Intercept 99.77 (89.80 - 109.74) <0.001 75.61 (43.93 - 107.28) <0.001 58.21 (50.56 - 65.87) <0.001 48.92 (24.93 - 72.92) <0.001 
First trimester 25(OH)D status (Adequacy/inadequacy) 7.53 (-1.00 - 16.06) 0.084 9.53 (1.12 - 17.94) 0.026 8.58 (2.21 - 14.95) 0.008 9.99 (3.62 - 16.36) 0.002 
Age (years) - - 0.21 (-0.57 - 0.99) 0.600 - - -0.08 (-0.67 - 0.51) 0.794 
Early pregnancy BMI (kg/m
2
) - - 1.06 (0.27 - 1.86) 0.009 - - 0.77 (0.17 - 1.37) 0.012 
Parity (number of labors) - - 2.48 (-1.19 - 6.16) 0.186 - - 1.94 (-0.84 - 4.72) 0.171 
Energy intake (kcal/d) - - -0.01 (-0.01 - -0.001) 0.020 - - -0.004 (-0.01 - -0.001) 0.016 
Leisure physical activity before pregnancy (no/ yes) - - 6.67 (-1.96 - 15.31) 0.130 - - 2.21 (-4.32 - 8.74) 0.507 
Homeostasis Model Assessment – Insulin Resistance - - -0.63 (-1.68 - 0.41) 0.234 - - -0.88 (-1.7 - -0.04) 0.039 
Gestational age (weeks) 6.51 (5.66 - 7.36) <0.001 6.46 (5.57 - 7.35) <0.001 3.75 (3.08 - 4.42) <0.001 3.67 (2.96 - 4.37) <0.001 
Squared gestational age -0.09 (-0.11 - -0.07) <0.001 -0.08 (-0.11 - -0.06) <0.001 -0.05 (-0.06 - -0.03) <0.001 -0.04 (-0.06 - -0.03) <0.001 
Random effects β (95% CI) P c β (95% CI) P c β (95% CI) P c β (95% CI) P c 
σ Gestational age 1.06 (0.70 - 1.61) 
<0.001 
1.07 (0.70 - 1.64) 
<0.001 
0.76 (0.52 - 1.12) 
<0.001 
0.76 (0.51 - 1.13) 
<0.001 Covariance (gestational age) 1.80 (-5.52 - 9.11) 2.24 (-5.09 - 9.56) 1.27 (-3.31 - 5.85) 1.97 (-2.64 - 6.57) 
σ Residual 201.13 (160.97 - 251.31) 207.22 (164.64 - 260.79) 126.78 (101.43 - 158.46) 131.56 (104.49 - 165.63) 
a 25(OH)D, total number of observations (data)=516; total number of groups (women=194), and mean of 2.7 observations per group; b  25(OH)D, total number of observations (data)= 497; total number of groups (women=192), 
and mean of 2.6 observations per group. The group refers to the number of women with at least one data point in time and observations refers to the total number of data points in time for all women; c p-values refer to 













Table 3. Linear mixed effects regression models between first trimester 25(OH)D status and changes in lipids concentrations during pregnancy, Rio de Janeiro/Brazil, 
2009-2012. 










Fixed effects β (95% CI) P
 c
 β (95% CI) P
 c
 β (95% CI) P c β (95% CI) P c 
Intercept 33.03 (29.95 - 36.12) <0.001 31.59 (22.43 - 40.75) <0.001 48.61 (39.60 - 57.61) <0.001 -18.46 (-54.69 - 17.77) 0.318 
First trimester 25(OH)D status (Adequacy/inadequacy) -0.51 (-2.94 - 1.92) 0.681 0.08 (-2.33 - 2.49) 0.946 -4.88 (-15.11 - 5.35) 0.350 -6.09 (-15.97 - 3.78) 0.227 
Age (years) - - 0.18 (-0.05 - 0.40) 0.122 - - 0.65 (-0.27 - 1.57) 0.165 
Early pregnancy BMI (kg/m
2
) - - -0.05 (-0.28 - 0.18) 0.664 - - 1.95 (1.02 - 2.88) <0.001 
Parity (number of labors) - - 0.28 (-0.77 - 1.34) 0.601 - - -0.28 (-4.61 - 4.05) 0.900 
Energy intake (kcal/d) - - -0.001 (-0.002 - 0.0001) 0.076 - - -0.001 (-0.01 - 0.004) 0.594 
Leisure physical activity before pregnancy (no/yes) - - 1.77 (-0.71 - 4.25) 0.161 - - 11.15 (1.02 - 21.28) 0.031 
Homeostasis Model Assessment – Insulin Resistance - - -0.15 (-0.48 - 0.18) 0.383 - - 1.86 (0.34 - 3.37) 0.016 
Gestational age (weeks) 1.94 (1.66 - 2.22) <0.001 1.93 (1.64 - 2.22) <0.001 3.54 (3.27 - 3.81) <0.001  3.54 (3.27 - 3.82)  <0.001 
Squared gestational age -0.04 (-0.05 - -0.03) <0.001 -0.04 (-0.05 - -0.03) <0.001 
- - - - 
Random effects β (95% CI) P c β (95% CI) P c β (95% CI) P c β (95% CI) P c 
σ Gestational age 0.05 (0.03 - 0.11) 
<0.001 
0.05 (0.02 - 0.11) 
<0.001 
1.20 (0.64 - 2.23) 
<0.001 
1.21 (0.62 - 2.35) 
<0.001 Covariance (gestational age) -0.04 (-0.75 - 0.67) 0.08 (-0.64 - 0.81) 12.41 (-1.15 - 25.98) 11.95 (-2.16 - 26.06) 
σ Residual 22.78 (18.22 - 28.49) 23.58 (18.64 - 29.83) 498.81 (402.13 - 618.73) 501.43 (398.94 - 630.25) 
a 25(OH)D, total number of observations (data)=516; total number of groups (women=194), and mean of 2.7 observations per group; b  25(OH)D, total number of observations (data)= 497; total number of groups (women=192), 
and mean of 2.6 observations per group. The group refers to the number of women with at least one data point in time and observations refers to the total number of data points in time for all women; c p-values refer to 
























Table 4. Linear mixed effects regression models between first trimester 25(OH)D status 

























































































































































































































































observations per group; b  25(OH)D, total number of observations (data)= 497; total number of groups (women=192), 
and mean of 2.6 observations per group umber of observations. The group refers to the number of women with at least 
one data point in time and observations refers to the total number of data points in time for all women; c p-values refer 
to maximum likelihood value; BMI = Body Mass Index. 
